Markus Warmuth
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 28
- Chronic Myeloid Leukemia Treatments 22
- Acute Myeloid Leukemia Research 6
- Genetics 17
- Chronic Lymphocytic Leukemia Research 17
- Co-authors
- Michael J. Hallek (11 shared papers)Doriano Fabbro (4 shared papers)Katja Zirlik (5 shared papers)Hendrik Veelken (5 shared papers)Christine Dierks (5 shared papers)Gang Xia (4 shared papers)S. Danhauser-Riedl (4 shared papers)Paul William Manley (4 shared papers)
- Journals
- Blood (7 papers)Nature (6 papers)Cancer Research (4 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Markus Warmuth
68 papers receiving 14.4k citations
Markus Warmuth's Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 2.4k
- Genetics 1.7k
- Cancer Research 2.0k
- Oncology 3.5k
- Molecular Biology 9.0k
Countries citing papers authored by Markus Warmuth
This map shows the geographic impact of Markus Warmuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Warmuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Warmuth more than expected).
Fields of papers citing papers by Markus Warmuth
This network shows the impact of papers produced by Markus Warmuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Warmuth. The network helps show where Markus Warmuth may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Warmuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Hit paper breakdown → | 2012 | 6169 |
| 2 | Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases Hit paper breakdown → | 2016 | 727 |
| 3 | Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors Hit paper breakdown → | 2010 | 513 |
| 4 | 2010 | 502 | |
| 5 | The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 Hit paper breakdown → | 2017 | 486 |
| 6 | 2008 | 444 | |
| 7 | H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers Hit paper breakdown → | 2018 | 413 |
| 8 | 2013 | 367 | |
| 9 | Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1 Hit paper breakdown → | 2018 | 360 |
| 10 | 2015 | 359 | |
| 11 | 2004 | 343 | |
| 12 | 2006 | 325 | |
| 13 | 2010 | 289 | |
| 14 | 2007 | 277 | |
| 15 | 2010 | 210 | |
| 16 | 2006 | 187 | |
| 17 | Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. | 1996 | 164 |
| 18 | 2010 | 164 | |
| 19 | 2006 | 153 | |
| 20 | 2006 | 132 |
About Markus Warmuth
Markus Warmuth is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Rheumatology, having authored 69 papers that have together received 14.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (17 papers), RNA modifications and cancer (8 papers), RNA Research and Splicing (8 papers), Eosinophilic Disorders and Syndromes (8 papers), Hedgehog Signaling Pathway Studies (8 papers), HER2/EGFR in Cancer Research (7 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (1.7k citations), Cancer Research (2.0k citations), Oncology (3.5k citations) and Molecular Biology (9.0k citations). Markus Warmuth has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Michael J. Hallek, Doriano Fabbro, Katja Zirlik, Hendrik Veelken, Christine Dierks, Gang Xia, S. Danhauser-Riedl, Paul William Manley, Sung Joon Kim and Marion Dorsch. Their work appears in journals such as Blood, Nature, Cancer Research, Proceedings of the National Academy of Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.